Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice

A. Zanichelli, M. Maurer, W. Aberer, T. Caballero, H. J. Longhurst, L. Bouillet, V. Fabien, I. Andresen, Unknown

Open source

DOI
10.1111/all.13103
Published
2017-03-13
Container
Allergy
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/all.13103,
  title = {Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice},
  author = {A. Zanichelli and M. Maurer and W. Aberer and T. Caballero and H. J. Longhurst and L. Bouillet and V. Fabien and I. Andresen and Unknown},
  year = {2017},
  journal = {Allergy},
  doi = {10.1111/all.13103},
  url = {https://doi.org/10.1111/all.13103}
}

RIS

TY  - JOUR
TI  - Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice
AU  - A. Zanichelli
AU  - M. Maurer
AU  - W. Aberer
AU  - T. Caballero
AU  - H. J. Longhurst
AU  - L. Bouillet
AU  - V. Fabien
AU  - I. Andresen
AU  - Unknown
PY  - 2017
JO  - Allergy
DO  - 10.1111/all.13103
UR  - https://doi.org/10.1111/all.13103
ER  - 

APA

Zanichelli, A., Maurer, M., Aberer, W., Caballero, T., Longhurst, H. J., Bouillet, L., Fabien, V., Andresen, I., & Unknown (2017). Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice. Allergy. https://doi.org/10.1111/all.13103

Source records